-
Published13/02/2025
-
Today23/03/2025
-
Deadline01/02/2027
-
Opening of tenders01/02/2027
Utilities
- indicates text translated automatically in your browsing language
Pharmaceutical contracts with accession option Text automatically translated in your browsing language Automatically translated
This notice does not concern the award of a public contract within the meaning of the Procurement Coordination Directive (2014/24/EU) or antitrust law. In order to provide the widest possible information to interested pharmaceutical companies, this notice is published in the Supplement to the Official Journal of the European Union. The procedural term "open procedure" (point IV.1.1) used in the context of this notice text is due to the specifications of the notice form. This and the use of the medium "TED" do not imply any submission to procurement regulations, the validity of which is not prescribed by law or procurement regulations. It is a framework contract with accession option covering various active substances. Text automatically translated in your browsing language Automatically translated
https://beschaffungen.barmer.de/
https://beschaffungen.barmer.de/
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.